| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | VP, Corporate Development
4 companies
Barthelemy Nicolas is a Director at STANDARD BIOTOOLS INC. with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 9 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | RGEN Repligen Corp | Director | Buy | 1,200 | $125.45 | $150,540.00 | +34.6% | +13.0% | +1.5% | |
| May 11, 2022 | TWST Twist Bioscience Corp | Director | Buy | 8,550 | $29.25 | $250,096.05 | +158.7% | +82.3% | -52.3% | |
| Oct 29, 2021 | RGEN Repligen Corp | Director | Sale+OE | 1,645 | $288.20 | $474,085.40 | -32.3% | -39.0% | -37.4% | |
| Jun 24, 2021 | MASS 908 Devices Inc. | VP, Corporate Development | Sale+OE | 13,000 | $39.72 | $516,370.00 | -49.0% | -7.7% | -52.1% | |
| Dec 22, 2020 | MASS 908 Devices Inc. | Director | Buy | 14,000 | $20.00 | $280,000.00 | New | - | - | |
| Nov 9, 2020 | RGEN Repligen Corp | Director | Sell | 1,214 | $195.51 | $237,349.14 | -45.6% | - | - | |
| May 18, 2020 | RGEN Repligen Corp | Director | Sale+OE | 3,009 | $142.53 | $428,872.77 | -53.0% | - | - | |
| Apr 22, 2020 | RGEN Repligen Corp | Director | Sale+OE | 2,688 | $109.99 | $295,653.12 | -47.0% | - | - | |
| Apr 3, 2020 | RGEN Repligen Corp | Director | Sale+OE | 2,688 | $99.99 | $268,773.12 | -39.8% | - | - | |
| Mar 6, 2020 | LAB Standard Biotools Inc. | Director | Buy | 80,000 | $3.05 | $243,872.00 | +115.3% | - | - |